Events

Oct 2025

• Mon 6

  • 12:15 pm - 1:15 pm EDT

    Clinical Case Discussion: An Adult Patient with Uncontrolled Moderate-to-Severe Atopic Dermatitis and a Treatment Option for Appropriate Patients 6+ Months of Age
    by Andrew Baker, PA-C

• Tue 7

  • 12:15 pm - 1:15 pm PDT

    The Many Faces of Type 2 Inflammation: Unraveling Its Role Across Dermatologic Conditions and a Treatment Option for Appropriate Patients
    by Justin Love, PA-C

• Wed 8

  • 12:15 pm - 12:45 pm EDT

    A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation
    by Gina Mangin, PA-C

• Thu 9

  • 12:15 pm - 1:15 pm CDT

    Exploring the Pathophysiology of Type 2 Inflammation in Chronic Spontaneous Urticaria (CSU) and a Treatment Option for Appropriate CSU Patients 12+ Years of Age
    by Cynthia Trickett, PA-C

• Tue 14

  • 12:15 pm - 1:15 pm EDT

    DUPIXENT^@ (dupilumab) Pediatric Caregiver Story followed by A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation
    by Lisa Swanson, MD

• Wed 15

  • 12:15 pm - 1:15 pm CDT

    Beneath the Itch: The Role of Type 2 Inflammation and a Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation
    by Ty Hanson, DO

  • 12:15 pm - 1:15 pm PDT

    Pearls and Common Challenges for the Diagnosis of Bullous Pemphigoid (BP)
    by Matthew Lewis, MD

• Thu 16

  • 12:15 pm - 1:15 pm EDT

    Clinical Case Discussion: An Adult Patient with Prurigo Nodularis and a Treatment Option for Appropriate Patients 18+ Years of Age
    by Michael Payette, MD

  • 12:15 pm - 1:15 pm CDT

    Clinical Case Discussion: A Pediatric Patient with Uncontrolled Moderate-to-Severe Atopic Dermatitis and a Treatment Option for Appropriate Patients 6+ Months of Age
    by Dareen Siri, MD

• Mon 20

  • 12:15 pm - 1:15 pm CDT

    DUPIXENT^® (dupilumab) Pediatric Caregiver Story followed by A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation
    by Dareen Siri, MD